Investing Profile

Raphael Wisniewski

InvestorVC

Associate at Andera Partners

Your Intro Paths to Raphael Wisniewski

Signal uses Gmail to reveal intro paths. Email content is never read.

Find Raphael Wisniewski on

Current Investing Position

Investment Range

$5.0M - $35.0M

Sweet Spot

$20.0M

Investments On Record

Raphael Wisniewski is on these Sector & Stage Rankings

Raphael Wisniewski's Investments On Record (12)

Company	StageDateRound Size	Total Raised
Exciva	Series BJan 2026$62M Series AOct 2021$10M	$72M
Co-investors: Sofia Ioannidou (Andera Partners), Philip Scheltens (EQT Life Sciences), Reetika Bhardwaj (ARCH Venture Partners)
Spiro Medical	Series AJan 2026$67M	$67M
Artios Pharma	Series DNov 2025$120M Series CJul 2021$150M Series BAug 2018$83M	$380M
Co-investors: Florian Müllershausen (Novartis Venture Fund), Barbara Dalton (Pfizer Venture Investments), René Kuijten (EQT Life Sciences), Hakan Goker (M Ventures (Merck)), Nikola Trbovic (Pfizer Venture Investments), Jake Simson (RA Capital)
EG 427	Series BFeb 2025$28M	$28M
ENYO Pharma	Series CJan 2024$43M Series BJun 2018$47M	$120M
Co-investors: Iain Dukes (OrbiMed), Carl Gordon (OrbiMed Advisors)
BioVentrix	Series AApr 2023$49M	$49M
SoniVie	Series CJan 2023$60M	$60M
Amolyt Pharma	Series CJan 2023$140M	$290M
Co-investors: Ohad Hammer (Pontifax Venture Capital), Thierry Laugel (Kurma Partners), Felice Verduyn - van Weegen (EQT Life Sciences), Iyona Rajkomar (Pontifax Venture Capital)